昊海生科(688366.SH)業績快報:2020年度淨利降37.95%至2.3億元
格隆匯2月25日丨昊海生科(688366.SH)披露2020年度業績快報,報吿期內,公司實現營業收入13.32億元,同比下降16.95%;實現利潤總額2.57億元,同比下降40.82%;實現歸屬於母公司股東的淨利潤2.30億元,同比下降37.95%;實現歸屬於母公司股東的扣除非經常性損益的淨利潤2.07億元,同比下降42.22%;報吿期末公司總資產63.00億元,較期初增長2.41%;歸屬於母公司股東的所有者權益54.91億元,較期初增長0.66%。
報吿期內,新冠肺炎疫情給全球經濟帶來嚴重的負面衝擊。公司產品主要應用於眼科門診及擇期手術、整形美容門診、骨關節腔注射診療以及非急診外科手術等,相關手術及診療服務在疫情期間均被納入臨時停診範圍,公司業務受限顯著,各產品線主營業務收入均較上年同期有所下降。其中,第一季度公司業務受到疫情影響尤為顯著,自第二季度起,隨着疫情得到逐步控制,公司亦採取積極措施恢復生產經營,各產品線營業收入較上年同期降幅明顯收窄。2020年上半年,公司營業收入較上年同期下降36.85%。自第三季度起,除眼科海外業務繼續受到全球疫情影響外,公司國內業務進一步呈現出強勁復甦的態勢,各主要產品線銷售收入均已成功扭轉下降趨勢。報吿期內,公司毛利率與上年相比基本維持穩定,整體收入的下降導致報吿期內利潤總額以及歸屬於母公司股東的淨利潤的下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.